Price (delayed)
$56.65
Market cap
$3.13B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.69
Enterprise value
$2.9B
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic
There are no recent dividends present for PRCT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.